Multiple Sclerosis (MS): Clinical Trials

3 trials for Multiple Sclerosis (MS), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow Multiple Sclerosis (MS): new trials by email Literature Review of Multiple Sclerosis (MS) trials Research Report on Multiple Sclerosis (MS)

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis
ANK-700, Placebo - Multiple Sclerosis (MS), Relapsing Remitting Multiple Sclerosis
Phase 1CompletedAnokion SA342020-11-062025-05-31
A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis
Ocrelizumab, rHuPH20 - Multiple Sclerosis (MS)
Phase 1CompletedHoffmann-La Roche1342019-08-122025-07-08
Avonex®: Safety, Blood Levels and Effects
Interferon beta 1a, (IM) AVONEX® - Multiple Sclerosis (MS)
Phase 1CompletedTrio Medicines Ltd.772001-01-012013-05-27

Narrower conditions

Multiple Sclerosis (3)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Respiratory Aspiration (1)

Broader conditions

Autoimmune Diseases (3)  ·  Autoimmune Diseases of the Nervous System (3)  ·  Demyelinating Autoimmune Diseases, CNS (3)  ·  Demyelinating Diseases (3)  ·  Immune System Diseases (3)  ·  Nervous System Diseases (3)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)

Interventions

Interferon beta-1a (1)  ·  ocrelizumab (1)

Sponsors

Anokion SA (1)  ·  Hoffmann-La Roche (1)  ·  Trio Medicines Ltd. (1)

Countries

United States (2)  ·  United Kingdom (1)

Top investigators

Steve Warrington (1)

Results publications

PMID 39460719, PMID 41758576